Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Circ Genom Precis Med. 2019 Oct 22;12(11):e002723. doi: 10.1161/CIRCGEN.119.002723

Table 1.

Study Characteristics

Study Country Probands, n Detection of Index Cases Family Members, n Contact and Collection Testing
Bhatnagar et al14 United Kingdom 259 SBR 200 Letter advising an appointment with PCP Biochemical
Umans-Eckenhausen et al16 The Netherlands 237 Diagnostic protocol followed by GT 5442 Nurse home visit LDLR+Biochemical
Vergotine et al19 South Africa 379 GT 790 LDLR
Marks et al15 United Kingdom 227 SBR 165 Letter with choice of home visit or an SAC visit Biochemical
Hadfield et al13 United Kingdom 733 SBR 769 Letter advising an appointment with GP or to attend SAC Biochemical
Muir et al24 New Zealand 76 GT 353 Letter advising to attend SAC LDLR, APOB
Bell et al17 Australia 100 GT 366 Letter with telephone counseling and advice to attend SAC LDLR, APOB, PCSK9
Jannes et al20 Brazil 248 GT 394 Referral to SAC LDLR, APOB, PCSK9
Latkovskis et al18 Latvia 140 DLCN score 68 Biochemical
Alver et al23 Estonia 21 GT 64 Family member directed invite to SAC LDLR, APOB, PCSK9

DLCN indicates Dutch Lipid Clinic Network; GP, general practitioner; GT, genetic testing; PCP, primary care provider; SAC, study-associated clinic; and SBR, Simon Broome Register.